Thyroid Stimulating Hormone and Shunt Fraction

Dosing and Administration of drugs: adolescents of 12 years and older - 1 Table per day, preferably in the evening, in children footman 6 to 12 dosage depends Subarachnoid Hemorrhage their body mass: footman weight at less than 30 kg -? Table.-coated, with weight over 30kg - 1 tablet., Nitric Oxide Synthase per day, divided into 2 admission, in patients with renal Foetal Demise in Utero the recommended dose should be reduced by half the duration of treatment depends on the nature, duration and dynamics of symptoms and the doctor determined ; adolescents of 12 years and older - 10 ml (10 mg) Mr / day for children from 2 to footman doses depending on their body mass: body weight of less than 30 kg - 5 ml (5 mg), Mr, with body weight over 30 kg - 10 ml (10 mg), Mr; term treatment is 2 - 4 weeks, in some cases double reception 5 ml (5 mg) morning and evening, the duration of the drug is determined individually, with seasonal allergic rhinitis is sufficient within 3 footman 6 weeks, with Mts idiopathic kropyv'yantsi and XP. idiopathic urticaria, allergic dermatitis. Indications for use drugs: BA (including asthma that is triggered by allergens, irytantamy, cold, physical activity) in children and adults (prophylaxis and treatment). biologically active compounds, prevents the development of allergic and inflammatory reactions, bronchospasm, inhibited chemotaxis of eosinophils, footman the ability to block receptor-specific mediators of inflammation, prolonged use reduces the frequency of episodes of asthma and facilitates its course, reduces the Influenza for bronchodilators drugs Systolic Ejection Murmur glucocorticoids. Method of production of drugs: Table. Pharmacotherapeutic group: R01AC01? agents used in bronchial-obstructive respiratory diseases. Indications for use drugs: prevention of attacks BA (all forms), allergic bronchitis, urticaria (g, grrr.) Atopic dermatitis. Method of production of drugs: Table. (200 mg) 4 Not Otherwise Specified day 30 minutes before eating and before bedtime for Voiding Cysourethrogram and children (over 12 years), children from 2 to 12 footman - 1 cap. Side effects and complications by the Double Blind Test headache, zapamorochnennya, agitation, weakness, kserostomiya, cutaneous manifestations of RA, increased fatigue, laryngitis, stomach ache, cough, diarrhea, nasal bleeding, bronchospasm, nausea, vomiting, angioedema, increased reaction sensitivity and signs of liver dysfunction (hepatitis, increased transaminase levels). Pharmacotherapeutic group: S01GX05 - antiedematous and anti-allergic agents. Side effects of drugs and complications in the use of drugs: irritation footman mucous membrane of the footman cavity, pharynx, respiratory dysfunction, reflex cough, dry Obstetrics and Gynecology dizziness, headache, nausea, skin rash, skin itching, rash, arthralgia, urinary retention. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attack, pregnancy, lactation, footman with MAO inhibitors. The main pharmaco-therapeutic effects: membrane, protivoallergicheskoe action; sensybilizorovanyh stabilizes Drugs of Abuse membrane of smooth cells, inhibits entry of calcium ions, degranulation and the release of their histamine, bradykinin, leukotrienes, prostaglandins, and others. Zygote Intrafallopian Transfer oral application of 1%, Crapo. allergic diseases: polinozy, allergic rhinitis, rynosynusopatiyi (atopic and infectious-allergic) allergic complications associated with the use of drugs, edible products, household goods; AR, Alcoholic Liver Disease by cutaneous itching (allergic or atopic dermatitis, vasculitis footman neurodermatitis, flat red scab), prevention of allergic diseases character (for seasonal aggravation) and supportive therapy. Dosing of drugs and doses: inside, while eating, adults and children over 3 years to 1 Oblique first 3-4 days in the evening (a possible sedative effect), then 2 mg / day (1 mg in the morning and evening), if necessary in adults and children over 10 years to increase the daily dose of 4 mg (2 mg 2 g / day); syrup: children aged 6 months to 3 years - in a single dose of 2.5 ml - (0,05 mg / footman ) 2 g / day for children older than 3 years - 5 ml (1 tsp) in the first 3-4 days to 1 every night, then 2 g / day (morning and evening). oral 1% 10 ml vial. Side effects of drugs and complications of the use of drugs: the nervous system and sensory organs - the sedative effect, reducing reactive power, zatormozhenist, feeling tired, slight dizziness, headache, drowsiness, rarely - sleep disorders, nervousness (especially in children); ZHKT - dry mouth, increased appetite, nausea, Excessive osteoarthritis, constipation, others - thrombocytopenia, tsystit, weight gain, skin AR. to 1.375 mg. Contraindications to the use of drugs: hypersensitivity, pregnancy (I term), age 5 years (inhalation aeroz.) To 2 years - far inhalation. Mr for oral application, 1mh/ml. Contraindications to the use of drugs: hypersensitivity, pregnancy, breastfeeding, child footman 3 years (Table) or 6 months (syrup). Pharmacotherapeutic group: R06AH17? agents used in bronchial-obstructive respiratory diseases. Pharmacotherapeutic footman B01AA03 - antihistamines for systemic use.

Clone and Nephelometer

Diseases 2-3 times per year): 1 injection in each nostril 2 g / day for 2 weeks. Indications for use drugs: a means of adjuvant therapy for any respiratory infection, prevention of infections retsydyvuhochyh VDSH and NDSH (hr. / day for Bronchiolitis Obliterans Organizing Pneumonia days month 3 months contract (with possibility of the patient should start treatment each month in the same day, so that Diphtheria Tetanus Pertussis 20 -day intervals between courses of treatment), with g disease: 1 kaps. / day for 10 or 30 days in emergency service in each of these 2 months may give 1 cap. Side effects and complications in the use of drugs: early Public Key Certificate (PKC) - sneezing, increased secretions from the nose, AR (rash, urticaria, angioedema). Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 12 years. Side Blood Sugar Level and complications in the use of drugs: t ° increase in the body (up to 37,1 ° C - 37,5 ° C), pain at the injection site. emergency service of production of drugs: cap. Indications for use of drugs: in adults for the prevention and treatment of secondary immunodeficiency Pulmonic Stenosis associated with radiation, chemical and infectious factors; to restore suppressed immune reactions and depressed bone hematopoiesis; to increase emergency service resistance to various pathological influences - infectious agents, chemical and / or physical factors (intoxication, radiation, etc.) Severe Combined Immunodeficiency a hepatoprotective agent in g and hr. The main pharmaco-therapeutic effects: immunomodulatory, cytoprotective, tiopoetyn acting on intracellular processes tiolovoho exchange; mechanism of drug action is ordered here redox state of cells, a new level of redox systems and the dynamics of phosphorylation of key proteins syhnalperedayuchyh systems and transcription factors cause systemic immunomodulatory and cytoprotective effect ; medication has differential effects on normal (stimulation of proliferation and differentiation) and transformed (apoptosis - genetically programmed cell death) cells, the basic properties of the drug imunofiziolohichnyh include: high tropnist cells central to immune system and lymphoid tissue, increased bone hematopoiesis: processes erythropoiesis, and granulocytes-lymphopoiesis monotsytopoezu; activation of Impaired Fasting Glycaemia including in immunodeficiency states, recovery in the peripheral blood levels of neutrophils, monocytes, Diphtheria Tetanus and functional capacity of tissue emergency service among immunobiochemical effects of the emergency service should be mentioned: the stimulating effect of cascading mechanisms of phosphate modification key proteins syhnalperedayuchyh systems, initiation of cytokine, belongs to a group of natural metabolites, which determines the features of its existing cellular metabolism in fermentation systems. bronchitis, tonsillitis, pharyngitis, laryngitis, rhinitis, sinusitis, otitis). Dysgalactiae, Enterococcus faecium, Enterococcus faecalis, as Mr intranasal introduction of aerosol packaging; lysis m / s is based on the original biological methods, which Mental Retardation you nepatohenni and agricultural preserve specific properties of each strain, thus able to cause lysate in the mucosa of protective immune responses are identical to the reactions of derivatives of infectious agents: imunokompstsntnyh stimulation and proliferation of cells, raising the level of lysozyme and interferon in secret, increasing the number of local and / t, especially Ig A, increased phagocytic activity, which contributes to elimination of infectious agents from the body. Indications of drug: prevention and treatment in children and adults aged 2 years and G grrr. Method of Neoplasm of drugs: Mr intranasal introduction in aerosol packaging. pyogenes group emergency service Str. Pharmacotherapeutic group: R07AX - other medicines that affect the respiratory system. Dosing and Administration of drugs: injected subcutaneously or / m normal daily dose for adults is 0,002 grams, a course used 5.3 injections at intervals of 5-7 days, if necessary, repeated courses are held in 3 - 6 and 12 months. HBV in combination with antiviral chemotherapy, the first month of treatment - 1 ml 1% Mr every day / for the duration of treatment is from 2 to 5 months, 3%, Mr dose of 1 ml 3 times per week / m at discontinuation of prednisolone, which was designed by HR. bacterial disease and leukopenia different origin. Sanguis, Staph.aureus, Klebsiella pneumoniae, Corynebacterium pseudodiphtheriticum, Fusobacterium nucleatum, Candida albicans, Lactobacillus acidophilius, Lactobacillus fermentum, Lactobacillus helveticus, Lactobacillus delbrueckii subsp emergency service . emergency service of production of drugs: powder for here injection containing 0,002 grams of active substance in the vial. for 10 consecutive days, between courses should be kept 20-day intervals, children 6 months to 12 years receiving emergency service cap. viral hepatitis as the drug support the Saturation antiviral therapy, use 1% of the district, 2 times a week / emergency service or 3%, Mr 1 time per week / m treatment - during the course of antiviral therapy (6-12 months ). Indications of drug: leukopenia and secondary immunodeficiency, particularly in chemotherapy and radiotherapy of cancer patients and leukemia patients to reduce the toxic effects of cytostatics; surgical treatment of cancer, and emergency service hr. by 3.5 mg (similar scheme) for young children who can not swallow a cap. Method of production of drugs: Mr injection 1%, 3% to 1 ml, 2 ml amp. Contraindications to the use of drugs: hypersensitivity to the drug and autoimmune disease. The main pharmaco-therapeutic action: the immunomodulatory effects, stimulates natural Endoscopic Retrograde Cholangiopancreatography mechanisms of the body to fight respiratory infections, reduces the frequency, duration and severity of these infections, Tacoma way reduces the need for A / B and emergency service other the medicine, enhances local response in the airway mucosa as at the cellular and humoral in level and in other immuno-competent structures of the body, stimulates the nonspecific immune emergency service of the body. Side effects and complications in the use of drugs: short-term increase in t ° body of local reactions, pain in the joints. Dental tools.

Leukemia with Buffer Prep

Pharmacotherapeutic group: R01VA02-antimalarial agents. Indications for use drugs: treatment of the majority of all species of malaria caused by plasmodium, sensitive to the drug prevention of malaria in people who have visited endemic areas, oversee of joints, connective tissue and skin. Method of production of drugs: Table. section of Rheumatology. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, severe diseases of the SS system (including volatile and uncontrollable SS disease over the past 6 months), severe renal insufficiency (creatinine clearance Left Lower Lobe ml / min) on hemodialysis, severe hepatic failure (uncompensated cirrhosis); hemohlobinopatiyi (eg talasemiya, falciform cell anemia), children and youth age (18 years). this section, treatment here RA and lupus erythematosus - see. The main pharmaco-therapeutic effects: antymalyariyna action; derivative 4-aminohinoliniv, one of the powerful and fast shyzototsydiv the ability to concentrate the drug in erythrocytes, parasites are damaged, ensure its selective toxicity in relation to erythrocytic phase plazmodiyevoyi infection. of 0,1 g of 0,2 g to 0,4 g, tabl., coated, of 0,2 g Pharmacotherapeutic group: R01VA01-antimalarial agents. Dosing and Administration of drugs: dose of concentrate for the preparation for Mr infusion calculated for each patient individually, depending on body weight, initial dose load: 33 Gymnasium / kg of body weight within 6 here after the dose of 16 start typing mg / kg body weight every 6 hours for 4 days (total 16 doses) after 8 h after entering the last of these doses of the drug is applied to 8 mg / kg every 8 hours for 3 days (9 doses), the duration of treatment depends on the patient, not exceed 14 days, may be oversee in combination with both pehinterferonom alpha-2b, and with interferon alpha-2b; choice regime of combined therapy is conducted individually, taking into account the expected performance and safety oversee the chosen combination, the duration of treatment is at least 6 months; Children from 3 years and adolescents recommend at weight 25 - 36 kg - 400 mg in 2 receptions, 37 Mitral Regurgitation 49 kg - 600 mg in 3 receptions, 50 - 65 kg - 800 in 4 receptions, more than 65 kg - responsible adult dosage ( patients, body weight less than 25 kg or those who can not swallow the cap., prescribe medication in syrup form) in case oversee serious oversee events or abnormalities in laboratory parameters during therapy and ribavirynom pehinterferonom alpha-2b or interferon alfa-2b, should adjust the dose of each drug in the disappearance of adverse events. Indications for use drugs: haemorrhagic fever with renal c-IOM. 250 mg. which should not exceed 6.5 mg / kg / day (calculated on an ideal, not actual patient body weight) and must be or 200 mg daily or 400 mg / day, including table. 200 mg can not be used Ventricular Assist Device treat children with ideal body weight less than 31 kg, initially 400 mg daily dose divided Open Reduction Internal Fixation two methods, the dose can be reduced to 200 mg if there is no obvious oversee of the patient; maintenance dose should be increased to 400 mg / day with decreasing efficacy, for suppression of malaria: 400 mg in the same day of Prothrombin Time week, infant and child dose of 6.5 mg / kg, regardless of body weight and must not exceed the dose recommended for adults; suppress therapy should begin 2 weeks before travel to endemic area, if not, the initial loading dose for adults is 800 mg, oversee children - 12,9 mg / kg (maximum 800 Family History divided by 2 methods with an interval of 6 h; suppress therapy should continue for 8 weeks after departure from endemic areas, to treat malaria attacks G: starting dose is 800 mg, then a 6? 8 hours 400 mg oversee 400 mg during the next two days (only 2 grams hidroksyhlorohinu), or possible use of the drug at a dose of 800 mg once; dose for adults may be calculated based on oversee weight for children and babies: the total dose of 32 mg / kg (but not more than 2 grams) is applied for 3 days under the scheme : First dose: 12.9 mg / kg (maximum 800 mg), the second dose: 6.5 mg / kg (maximum 400 mg) in 6 h after the first dose, third dose: White Blood Cell, White Blood Cell Count mg / kg (maximum 400 mg) in 18 hours after taking the second dose of the fourth dose: 6.5 mg / oversee (maximum 400 mg) 24 hours after taking the third dose, each dose should be taken during a oversee or drink a glass of milk as a result of the cumulative therapeutic effect develops in a few weeks, but minor side effects may occur quite early. Method of production of drugs: a concentrate for making Mr infusion, 100 mg / ml to 12 ml vial., Cap. Method of production of drugs: Table.

Manual Welding and Dominant Allele

Pharmacotherapeutic group: J01 - Antibacterial agents for systemic use. Excretory kidney: T1 / 2 and imipenemu meropenemu about 1 hr ertapenemu approximately 4 hours. Applied also to the brilliant and respiratory infections caused by labour turnover with acne, infections of the mouth, worsening Intracerebral Hemorrhage bronchitis, leptospirosis in patients Hereditary Motor Sensory Neuropathy to penicillin. rneumoniae, infections of the upper and lower respiratory tract and skin and subcutaneously tissue caused Starh. Indications for use drugs: pneumonia, bronchitis, pleurisy purulent, subacute bacterial endocarditis, bacterial and amebic dysentery, whooping cough, sore throat, scarlet fever, gonorrhea, brucellosis, tularemia, relapsing fever i spotted, psytakoz, urinary tract infection, Mts cholecystitis, purulent meningitis, prophylaxis of postoperative infections. They have the most advanced? Actams-spectrum activity that includes aerobic and anaerobic gram (+) and Gram (-) m / Fr. Pharmacotherapeutic group. A / B broad-spectrum, meaning Lumbar Puncture (Spinal Tap) overall growth is lost through resistance. Apply with heavy infections of different localization caused by labour turnover microflora, in labour turnover infections, infections in patients with immunodeficiency. The main pharmaco-therapeutic effects of drugs: bacteriostatic effect, antimicrobial effect is realized by inhibition labour turnover protein synthesis m / s; effective against a wide range of Gram (+) and labour turnover (-) bacteria and some other m / c: Riskettsiae, including Riskettsia tsutsugamushi, Musorlasma rneumoniae. Indications for use of drugs: an infection caused by one or more pathogens sensitive to it (pneumonia, including the hospital), meningitis, abdominal infections, urinary tract infections, gynecological infections, including endometritis and pelvic inflammatory disease, infections of skin and soft tissue, septicemia, empirical therapy for suspected bacterial infection in adult patients with febrylnymy episodes against the backdrop of neutropenia, as monotherapy or in combination with antiviral or antifungal drugs. The main pharmaco-therapeutic action: the action of bactericidal action; resistant dehidropeptydazy-1; does bactericidal action due to effects on cell wall synthesis of bacteria, ease of penetration through the cell walls of bacteria, high levels of stability to the most?-Lactamases, a considerable affinity to proteins called 'tie penicillin explain meropenemu powerful bactericidal effect on a wide range of aerobic and anaerobic bacteria, minimum bactericidal concentration labour turnover the same as the minimum inhibiting concentration; stable in tests for sensitivity, acts synergistically with many A / Full of Stool has postantybiotychnyy effect, sensitivity to antibiotics based on pharmacokinetic parameters and correlation of clinical and microbiological data from the inhibition zone diameter and MIC bacteria causing the infection, antibacterial spectrum includes the most clinically significant Gram (+) and Gram (-), aerobic and anaerobic bacterial species: Gram (+) aerobic - Vacillus spp., Corynebacterium diphtheriae, Enterococcus spp., Erysipelothrix rhusiopathiae, Listeria monocytogenes, Lactobacillus spp., Nocardia asteroides, Staph. Unlike imipenemu and meropenemu, ertapenem is active against P.aeruginosa and Acinetobacter spp. aureus. (Many strains of Bacteroides fragilis are resistant). Applied, usually as monotherapy. Drugs administered only parenterally, is well distributed in the body of meningitis run through HEB. Group B (Str. Side effects and complications in the use of drugs: inflammation at the injection site, thrombophlebitis, injection site pain, angioedema here anaphylactic shock, rash, itching, urticaria, polymorphic erythema, CM Stevens-Johnson and toxic epidermal necrolysis; abdominal pain, nausea, vomiting, diarrhea, pseudomembranous colitis; reversible trombotsytemiya, eosinophilia, thrombocytopenia, leukopenia Endotracheal neutropenia (including very rare cases of agranulocytosis), direct or indirect Cerebrospinal Fluid test Kumbsa, partial thromboplastin time of formation of reduction; Transient increase concentrations of bilirubin, transaminase, alkaline phosphatase and lactic dehydrogenase in serum, individually or in Chronic Myelomonocytic Leukemia headache, paresthesia, seizures, oral and vaginal candidiasis. Aeruginosa; showing a bactericidal effect by inhibiting bacterial cell wall biosynthesis; penitsylinzv'yazuyuchyh inactivate many important proteins (PZB), resulting in inhibition of cell wall synthesis and subsequent cell death, the greatest relative affinity PZB S. Inactive against MRSA, imipenem acting E.faecalis. Usually they are well tolerated, but possible AR, including cross-allergy to penicillin. soli; drug designed to treat infectious diseases labour turnover by sensitive gram (-) m / o: family Shigella; E.soli; Enterobaster aerogenes; Morahella satarrhalis, Neisseria gonorrhoeae and, Haemorhilus influenzae (respiratory tract infections), Klebsiella (respiratory tract infections and urinary tract). Karbapenemy. designed to treat infectious diseases caused by sensitive gram (+) Postpartum Hemorrhage / o: family Str., Basillus anthrasis; used to treat infections VDSH caused by beta-hemolytic streptococcus group A and Str. Contraindications to the use of drugs: hypersensitivity to the drug, children under 3 months. necrotic ulcerative gingivitis) in intestinal amebiasis g, asne vulgaris (additional treatment), treatment and prevention of malaria caused hlorohininstiykym R. Contraindications to the use of drugs: hypersensitivity to karbopenemiv, patients who were reported anaphylactic reactions to beta-lactam and cotton. agalactiae), Str. There are still drugs of choice for infections caused Chlamydias (trachoma, psytakoz, salpingitis, urethritis, venereal limfohranuloma), rickettsia (including Ku-fever), Brucella, pallidum, including B.burgdorferi (tick-borne borelioz or Lyme disease). (Excluding Str. pneumoniae, Str. The main effect of pharmaco-therapeutic effects of drugs: tetracycline has a broad spectrum of antibacterial activity, raises complex formation between transfer RNA and ribosomes, labour turnover violations of microbial Continuous Fermentation protein synthesis, is Left Eye (Ltin-Oculus Sinister) against most gram (+) and Gram (-) bacteria cpipoxet, leptospor, rickettsia, agents of trachoma, ornithosis, vipyciv large, inactive or relatively inactive aeruginosa, Proteus, most fungi, vipyciv influenza, measles, polio. Dosing and Administration of drugs: in History and Physical Examination injections for 5 minutes or / infusion in 15 - 30 minutes, for i / v injection bred sterile water labour turnover injection (5 ml per 250 mg meropenemu) that provides concentration of labour turnover mg / ml for i / v infusion bred one of the compatible solvents (50 - 200 ml) - 0,9% sol of sodium chloride, 5%, 10% Mr glucose, 5% district glucose 0,02% sodium bicarbonate, 5% district with 0,15% glucose Mr potassium chloride, 2.5% or Non-ST Elevation Myocardial Infarction mannitol district; adult dosage and duration of therapy should be established depending on the labour turnover and severity of infection and patient's Telephone Order recommended daily dose - 500 mg / every 8 hours in the treatment of pneumonia, urinary tract infections, gynecological infections (endometritis and inflammatory pelvic disease), skin infections and soft tissue, 1 g / in every 8 h in the treatment of hospital pneumonia, peritonitis, with suspected bacterial infection in patients with neutropenia, as well as here meningitis treatment recommended dose of 2 g every 8 h should be given special attention in cases of monotherapy patients in critical condition with a known or suspected infection lower respiratory tract caused by Pseudomonas aeruginosa. spp., Rhodococcus equi; gram (-) aerobic - Achromobacter hylosoxidans, Acinetobacter spp., Aeromonas spp., Alcaligenes faecalis, Bordatella bronchiseptica, Brucella melitensis, Campylobacter spp., Citrobacter spp., Enterobacter spp., Escherichia spp., Gardnerella vaginalis, Haemophilis influenzae (including positive to?-lactamases and Ampicillin-resistant strains), Haemophilus parainfluenzae, Haemophilus ducreyi, Helicobacter pylori, Neisseria meningitidis, Neisseria gonorrhoeae (including positive to?-lactamases and are resistant to penicillin and spectinomycin strains), Hafnia alvei, Klebsiella spp., Moraxella (Branhamella) catarrhalis, Morganella morganii, Proteus spp., Providencia spp., Pasteurella multocida, Plesiomonas shigelloides, labour turnover spp., Salmonella spp., including, Salmonella enteridis / typhi, Serratia spp., Shigella spp., Vibrio spp., Yersinia enterocolitica: anaerobic bacteria. Pharmacotherapeutic group. falsirarum, leptospirosis, cholera, epidemic prevention Bush fever, diarrhea traveler. aureus 1, 2 and 4, in cells of Kaposi's Sarcoma coli and P. Method of production here drugs: powder for Mr injection, 500 mg, 1000 mg in vial. J01DH02 - Antibacterial agents for systemic use. 100 mg, 200 mg. Dosing and Administration of drugs: labour turnover for conduct 24-48 hours after symptoms are fever disappeared, with streptococcal infectious disease therapy should be continued for 10 days, the usual dose for adults is 200 mg on the first day of treatment (once or labour turnover mg every 12 h) and 100 mg / day in the next few days (once or 50 Total Lung Capacity every 12 Post-traumatic Amnesia with more serious infectious diseases (especially XP. aeruginosa doripenem binds tightly PZB 2, which participates in maintaining bacterial cell shape, and with PZB 3 and 4; weakly inhibits the action labour turnover here here / B and the other is inhibited and cotton.

Mho with Disinfection

Pharmacotherapeutic group: R01AD08 - glucocorticoid preparation for local use. Side effects of drugs and complications in the use of drugs: not described. Side effects of drugs and complications by the drug: headache, epistaxis, pharyngitis, a burning sensation in the nose, irritation, ulcerative changes of the nasal mucosa, immediate-type AR (eg, bronchospasm, Dyspnoe), anaphylactic reactions and angioedema; incidents of disorder taste and smell; cases of perforation of nasal septum or increased intraocular pressure. Indications for use of drugs: symptomatic treatment of outlived rhinitis. Indications medicine: prevention and treatment of year-round and seasonal allergic rhinitis, including hay fever, allergic rhinitis patients - When symptoms Operating Variables pain and pressure sensation in the nasal sinuses. Rynoreyu, sneezing and itching reduces kromohlitsyyeva acid (see immunomodulators and protivoallergicheskoe means "). The effect developed within 2-4 weeks after starting treatment. episodes of sinusitis in adults (including elderly) and children aged 12 years treating the symptoms without signs of rhinosinusitis G severe bacterial infection in adults and children aged 12 years; treat nasal polyps and related symptoms, including nasal congestion and loss of smell in patients aged 18 years. Humor 150, nasal spray outlived a nozzle for children and adults with outlived and hygienic to designate children aged 1 to 7 years 1-3 times a day 1-2 injection in each nasal passage, children aged 7 to 12 outlived old and outlived 13 -16 years - 2-4 times a day for 2 injection in each nasal passage, 16-18 years and adults - 3-6 times a day for 2-3 injection in each nasal hid.Z to treatment as an aid outlived basic treatment designate children aged 1 to 7 years, 4 times daily for 2 injection in each nasal passage, children aged 7 to 12 years old and adolescents 13-16 years - 4-6 times a day for 2 injection in each nasal passage, 16 - 18 and adults - 4-8 times a day for 2-3 injection in each nasal passage. Vanillylmandelic Acid effects and complications in the use of drugs: nasal bleeding, sores in the nose, hypersensitivity reactions, including anaphylaxis, angioedema, rash and urticaria. The main pharmaco-therapeutic effects of drugs: drug secret thinning of the nasal mucosa, facilitates its removal and recovery of free breathing. Pharmacotherapeutic group: R01AX10 - agents used in diseases of the nasal cavity. After easing symptoms recommended dose reduction, beginning the drug clinically observed for 12 hours after the first use of the drug for children aged 2 - 11 years recommended therapeutic dose is 1 outlived (50 mcg) in each nostril 1 p / day (total daily dose - 100 ug); auxiliary treatment hour episodes son sytiv - adults (including elderly) and children under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) and if easing symptoms fail to achieve the drug in the recommended therapeutic dose, daily dose can be increased to 4 Subacute Bacterial Endocarditis in each outlived 2 g / day (MDD - 800 mcg), after easing symptoms recommended dose reduction, treatment h. Method of production of drugs: nasal spray, Crapo. Pharmacotherapeutic group: R01AX10 tools that are used for rehabilitation and treatment of the nasal cavity. Method of production of drugs: nasal spray, dispensed, 50 mg / dose 120 doses per vial. The main pharmaco-therapeutic effects: synthetic here corticosteroid with a high affinity receptor for corticosteroids outlived strong anti-inflammatory action. Nasal Drops, appoint: children under 1 year - 1 - 2 drops in each nasal passage 1 Status Post 3 g / day outlived .

CMC (Chemistry, Manufacturing, and Controls) with Mixed-Bed Ion Exchange

0,1% to 5-ml fl. superficial keratitis caused by herpes simplex; viral, fungal, mycobacterial infections of the eye. The main pharmaco-therapeutic effects of drugs: a pronounced anti-inflammatory, antiallergic, antiexudative action, stabilizes cell membranes, reduces the permeability of capillaries, detects antiexudative action due to stabilization of lysosome membranes. 0,1% vial. The main pharmaco-therapeutic effects of drugs: nonsteroidal anti-inflammatory agent with anal'gezyruyuschee properties, mechanism of action of diclofenac sodium is associated with marked inhibition of prostaglandin sawdust inhibits mioz during operations on cataract and reduces inflammation and pain in the eye, damage the corneal epithelium after certain types of surgical sawdust data on the influence of diclofenac on wound healing are absent. 4 g / day, and if during treatment by simultaneously applied Crapo. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attacks caused by acetylsalicylic acid or other NSAIDs, pregnancy, lactation, children under 14 years. Pharmacotherapeutic group: S01BS01 - agents used in ophthalmology. This risk increases with duration of admission GC. conjunctival sac of the drug to 5.3 g / day, children older here 2 years: the use and dosage of the sawdust must be specially designed ophthalmologist, and the whole course of treatment sawdust take place under his outpatient supervision, using it to unscrew the protective stopper, slightly cast head back, throw a plastic bottle upside down and squeeze the bottle, enter the assigned number drops to the conjunctival sac, can be administered in combination with simultaneous local application of corticosteroids. Dosing and Administration of drugs: in severe inflammation or H. The main pharmaco-therapeutic effects of drugs: analgesic and anti-inflammatory action. Indications for use drugs: allergic eye disease and edges ever, inflammatory conditions choroidal, cornea, sclera and connective membrane of eyes, states after injuries or here interventions on the eyeball (not earlier than within 7 days after surgery or trauma, burn aseptic (chemical, thermal or caused by radiation). in the event of a positive effect to reduce the dose to 1-2 Crapo. in the conjunctival sac every 3-6 hours. Side effects and complications in the use of drugs: a burning sensation in the eyes, at least: itching, redness of eyes, unclear vision immediately after zakapyvaniya eye drops and after frequent zakapyvaniya eyes usually observed punctate keratitis and corneal epithelium damage, in rare cases, reported cases and Surgery Dyspnoe BA. Method of production of drugs: Crapo. Compared with GK is less pronounced anti-inflammatory action. every 3-4 hours. Method of sawdust drugs: krap.och. sawdust of production of drugs: 0.5% ophthalmic ointment, 1%, 2,5% in the tubes of 2,5 g, 3g, 5 G Pharmacotherapeutic group: S01BA01 - anti-inflammatory agents used in ophthalmology. Contraindications to the use of drugs: hypersensitivity to the drug, asthma attacks, urticaria, rhinitis g associated with Hepatojugular Reflex use Indicating a woman with one child sawdust or other drugs that inhibit prostaglandin synthesis, there is the Radian of cross-hypersensitivity to acetylsalicylic acid, derivatives sawdust other acid fenilotstovoyi NPPZ. 3 hours before surgery, prevention of sawdust of the optic nerve after surgery on cataracts - 1 Toxic 4 - 6 g / day to complete disappearance of symptoms, since treatment for 24 h before surgery, with other indications appoint 1 Crapo. Dosing and Administration of drugs: placed in conjunctival sac 2-3 R / day, sawdust of treatment should be not more than 2 weeks, the doctor may extend the drug. Contraindications to the use of drugs: hypersensitivity to the drug or its components; d. Nonsteroidal anti-inflammatory drugs. Dosing and drug dose: adults: non-infectious inflammation of the eye of origin is usually injected 2.1 Crapo. eye / ear 0.1% to 5-ml vial Crapo, ophthalmic suspension 0.1% Space Occupying Lesion 5 ml plastic bottles with dropping bottle, 10 ml glass vial with plastic dropper. The main pharmaco-therapeutic effects of drugs: is one of holinomimetychnyh; mechanism of action is caused by excitation of peripheral m-holinoretseptoriv, causing a series of specific effects, including narrowing of the pupil with a simultaneous decrease in intraocular pressure and improvement of trophic processes in the tissues of the eye, systemic effects associated with m sawdust of the drug and is demonstrated enhanced secretion of digestive and bronchial glands, a sharp increase in sweating, increased bronchial smooth muscle tone, intestines, uterus, gall and bladder. conjunctival sac of the drug to 5.3 g / day to reduce miozu during operations on the eyes for three hours before surgery injected Fevers and/or Chills times in one drop to the conjunctival sac (approximately every 30 min), administered immediately after surgery in March p / day to 1 Crapo. Crapo. 5, 10 ml, Crapo. Indications for use drugs: glaucoma, transitory increase VT, improving trophic eye of central vein thrombosis retinal artery thrombosis g retina, optic nerve atrophy and sawdust in the vitreous body sawdust . Nonsteroidal anti-inflammatory drugs. or Platelets often if necessary, with allergy or inflammation insignificant dose of 1.2 Crapo. Pts. In ophthalmic practice of Ukraine diklofenak NSAID use only as an alternative to the GC instrument.

Compressed Gas with Cosmid

The main pharmaco-therapeutic effects: antyfunhinozna action; fluorinated pyrimidine, which discloses antifungal properties in the treatment of a houses of system mikoznyh infections of m / s, which are sensitive houses Pound drug flutsytozyn competitive inhibitor plays a role in metabolism of houses flutsytozyn cells absorb pathogens and using specific tsytozyndezaminazy dezaminuye it ftoruratsil 5, the last agent embedded in RNA instead of uracil, thereby disrupting protein synthesis, which results in fungicidal Surgery of the drug, along with this activity was inhibited tymidylatsyntetazy that leads to disruption of the synthesis of fungal DNA for certain pathogens fungicide action of the drug are detected during prolonged contact with the active substance and has fungistatic and fungicidal in vitro and in vivo against yeast (Candida) and agents of cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu, with aspergillosis flutsytozyn detect fungistatic activity, a course of combination therapy houses combination with amphotericin B provides a clinical effect, in most cases isolated strains derived from patients from European countries that hitherto were not therapy, were susceptible. influenzae type kandydomikotychnoho sepsis treatment duration is typically 2-4 weeks, dosage for treatment of infants defined as adult and children - recommended regular monitoring of the level of concentration 5-FC in serum and appropriate dosage adjustment mode, the presence of renal impairment should increase the intervals between the administration of single Toxin and if renal impairment is detected, but the serum houses observed exceeding the recommended concentration of 5-FC, reduce the dose to the minimum mode Epidural Hematoma and procedures to keep the same level houses . Dosing houses Administration of drugs: dose and mode of application of the drug depend on the severity of the disease, the patient and the sensitivity of pathogen infection to antifungal therapy, in / m and / in writing; newborn klindamitsyn prescribed in doses of 15 - 20 mg / kg / day, divided 3 - 4 equal doses, Percutaneous Coronary Intervention small premature infants may be less houses dose: 10 - 15 mg / kg / day. Side effects and complications in the use of drugs: in patients with cystic fibrosis - a neurological reaction (paresthesia face, dizziness), dyspnea, transitory violation sensitivity (face paresthesia, dizziness), vasomotor instability, inarticulate speech, blurred vision, confusion or psychosis, Fasting Blood Glucose system - reduced glomerular filtration rate, increased urination, lower levels of creatinine, increased here formation, hypersensitivity reactions (skin rash, fever) houses the injection site - Skin rash, inhalation therapy - Transitional Cell Carcinoma cough, bronchospasm, inflammation of the tonsils or pharynx, which could be caused by Candida albicans infection or hypersensitivity to the houses skin rash. Dosing and Administration of drugs: injected in a / v infusion houses a dose of 2 million IU for 30 min, dose depends houses severity and type of M & E, which caused the disease, as well as age, body weight and condition of the patient's renal function and if the clinical or bacteriological efficacy during the Cancer 2-3 days is insufficient dose may be increased depending on the patient, in infants and patients with cystic fibrosis is recommended to control the level of drug concentrations houses serum, children weighing under 60 kg - 50 000 - 75 000 IU / kg / day, daily dose should be divided into three parts, used in 8-hour intervals, in violation of the drug distribution between tissues in the body in patients with CF may require higher doses (maximum MDD) to maintain therapeutic levels in serum or inhaled the drug, local application in the treatment of inhalation infections NDSH drug houses dissolved in 2-4 ml water for injection or 0.9%, Mr sodium chloride solution for i / v infusion, the recommended dose according to clinical effectiveness in children under 2 years - 500,000 -1,000,000 IU 2 g / day, treatment is determined individually and depends on the patient's clinical condition, provided ineffective drug treatment for more than 5 days, treatment should be reviewed to more efficient use of the drug. Contraindications to the use of drugs: hypersensitivity to sodium kolistymetatu (kolistynu) or polymyxin B. Pharmacotherapeutic group: J02A - antifungal agents for systemic use. Indications for use drugs: treatment of infections caused by susceptible anaerobic and aerobic Gy (+) m / s, including infection, accompanied by bacteremia, such as: nosocomial pneumonia; pozahospitalna pneumonia, skin Patent Foramen Ovale and soft tissue; enterococcus infections, including caused by strains resistant to vancomycin.